Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain

Clinical trial NCT02447848 · COMPLETED

Trial details

NCT number: NCT02447848
Sponsor: Talphera, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate-to-severe Acute Pain

Start date: 2015-10-01
Primary completion: 2016-06-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.